Prestige Consumer Healthcare Inc (NYSE:PBH) Receives $57.77 Consensus Target Price from Analysts

Shares of Prestige Consumer Healthcare Inc (NYSE:PBH) have received a consensus rating of “Hold” from the eight ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $61.07.

Several brokerages have recently issued reports on PBH. ValuEngine upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research report on Friday, July 26th. CIBC restated a “hold” rating and issued a $84.00 target price on shares of Prestige Consumer Healthcare in a report on Monday, May 27th. TheStreet upgraded Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a report on Tuesday, July 23rd. Finally, Zacks Investment Research upgraded Prestige Consumer Healthcare from a “sell” rating to a “hold” rating and set a $31.00 target price on the stock in a report on Tuesday, May 28th.

Shares of PBH stock traded down $0.76 during mid-day trading on Wednesday, hitting $32.78. 12,326 shares of the stock traded hands, compared to its average volume of 442,234. Prestige Consumer Healthcare has a twelve month low of $26.25 and a twelve month high of $41.76. The stock has a market capitalization of $1.72 billion, a price-to-earnings ratio of 11.80, a price-to-earnings-growth ratio of 1.91 and a beta of 0.91. The stock’s 50-day simple moving average is $31.86. The company has a current ratio of 2.16, a quick ratio of 1.43 and a debt-to-equity ratio of 1.63.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.01. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.81%. The company had revenue of $232.15 million for the quarter, compared to analysts’ expectations of $231.52 million. During the same period last year, the firm earned $0.68 EPS. The firm’s revenue for the quarter was down 8.6% on a year-over-year basis. Equities analysts forecast that Prestige Consumer Healthcare will post 2.81 earnings per share for the current year.

Several hedge funds and other institutional investors have recently modified their holdings of PBH. Thrivent Financial for Lutherans boosted its position in shares of Prestige Consumer Healthcare by 2.7% in the fourth quarter. Thrivent Financial for Lutherans now owns 13,137 shares of the company’s stock worth $406,000 after buying an additional 347 shares during the period. Arizona State Retirement System boosted its position in Prestige Consumer Healthcare by 1.1% during the second quarter. Arizona State Retirement System now owns 37,594 shares of the company’s stock valued at $1,191,000 after purchasing an additional 400 shares during the last quarter. Mason Street Advisors LLC boosted its position in Prestige Consumer Healthcare by 1.6% during the first quarter. Mason Street Advisors LLC now owns 27,545 shares of the company’s stock valued at $824,000 after purchasing an additional 445 shares during the last quarter. Diversified Trust Co increased its stake in Prestige Consumer Healthcare by 8.2% during the second quarter. Diversified Trust Co now owns 8,575 shares of the company’s stock valued at $272,000 after acquiring an additional 650 shares during the period. Finally, Legal & General Group Plc boosted its holdings in Prestige Consumer Healthcare by 2.4% during the fourth quarter. Legal & General Group Plc now owns 52,367 shares of the company’s stock valued at $1,618,000 after purchasing an additional 1,251 shares in the last quarter.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Article: Technical Analysis of Stocks, How Can It Help

Analyst Recommendations for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.